Insider NameBuy/SellCompany NameTickerAmountShares Change
Jun 03, 2024Jun 04, 2024Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$22.05$167,013-18.71%
Jun 02, 2023Jun 02, 2023Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$23.01$198,760-17.58%
Jun 06, 2022Jun 06, 2022Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$19.25$123,673-15.90%
Jun 17, 2021Jun 17, 2021Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$30.52$95,795-11.95%
May 28, 2021Jun 01, 2021Spiegelman Daniel K
Dir
SellMyriad Genetics IncMYGN$28.99$207,023-34.73%
Apr 01, 2019Apr 03, 2019Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$89$1M-22.09%
Mar 27, 2019Mar 29, 2019Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$90$9,000-0.16%
Jun 22, 2018Jun 27, 2018Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$99$990,005-16.37%
Apr 23, 2018Apr 26, 2018Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$82.15$908,497-15.03%
May 27, 2015Oct 14, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$130$4M-31.08%
Mar 16, 2017Mar 17, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$91.96$182,908-12.08%
Mar 06, 2017Mar 09, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$93.32$214,916-9.99%
Feb 28, 2017Mar 02, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$94.07$3M-58.00%
Jan 09, 2017Jan 10, 2017Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$90$450,000-21.65%
Nov 09, 2016Nov 14, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$90.61$2M-46.40%
Aug 01, 2016Aug 03, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$99.33$397,320-8.52%
Jun 06, 2016Jun 09, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$89.14$146,992-3.39%
Jun 07, 2016Jun 08, 2016Spiegelman Daniel K
Dir
SellRelypsa IncRLYP$19.31$19,562-45.02%
May 31, 2016Jun 02, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$89.88$2M-29.26%
May 23, 2016May 25, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$87.07$328,184-6.04%
Mar 02, 2016Mar 03, 2016Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$86.12$398,120-8.51%
Nov 16, 2015Nov 18, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$104.3$2M-41.47%
Jun 05, 2015Jun 08, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$122.3$201,669-5.52%
May 29, 2015Jun 04, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$124.73$688,876-14.85%
May 18, 2015May 28, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$130$4M-45.09%
May 18, 2015May 19, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$124.77$256,905-2.65%
Mar 25, 2015Apr 02, 2015Spiegelman Daniel K
Dir
BuyOncothyreon Inc.ONTY$1.61$32,127+32.98%
Mar 25, 2015Apr 01, 2015Spiegelman Daniel K
Dir
BuyOncothyreon Inc.ONTY$1.61$32,127+32.98%
Mar 02, 2015Mar 05, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$107$2M-18.41%
Mar 05, 2014Feb 10, 2015Spiegelman Daniel K
EVP
CFO
SellBiomarin Pharmaceutical IncBMRN$70.61$2,895-0.06%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.